These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31935133)

  • 21. The Impact of Community Engagement on Health, Social, and Utilization Outcomes in Depressed, Impoverished Populations: Secondary Findings from a Randomized Trial.
    Lam CA; Sherbourne C; Tang L; Belin TR; Williams P; Young-Brinn A; Miranda J; Wells KB
    J Am Board Fam Med; 2016; 29(3):325-38. PubMed ID: 27170790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys.
    Harris MG; Bharat C; Glantz MD; Sampson NA; Al-Hamzawi A; Alonso J; Bruffaerts R; Caldas de Almeida JM; Cia AH; de Girolamo G; Florescu S; Gureje O; Haro JM; Hinkov H; Karam EG; Karam G; Lee S; Lépine JP; Levinson D; Makanjuola V; McGrath J; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Rapsey C; Tachimori H; Ten Have M; Torres Y; Viana MC; Chatterji S; Zaslavsky AM; Kessler RC; Degenhardt L;
    Addiction; 2019 Aug; 114(8):1446-1459. PubMed ID: 30835879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examination of the Effects of an Intervention Aiming to Link Patients Receiving Addiction Treatment With Health Care: The LINKAGE Clinical Trial.
    Weisner CM; Chi FW; Lu Y; Ross TB; Wood SB; Hinman A; Pating D; Satre D; Sterling SA
    JAMA Psychiatry; 2016 Aug; 73(8):804-14. PubMed ID: 27332703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Commentary: Applying the Community Partners in Care Approach to the Opioid Crisis.
    Wells KB; Watkins KE; Hurley B; Tang L; Jones F; Gilmore J
    Ethn Dis; 2018; 28(Suppl 2):381-388. PubMed ID: 30202191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
    Compton MT; Weiss PS; West JC; Kaslow NJ
    Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):939-46. PubMed ID: 16247563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community Engagement Compared With Technical Assistance to Disseminate Depression Care Among Low-Income, Minority Women: A Randomized Controlled Effectiveness Study.
    Ngo VK; Sherbourne C; Chung B; Tang L; Wright AL; Whittington Y; Wells K; Miranda J
    Am J Public Health; 2016 Oct; 106(10):1833-41. PubMed ID: 27552274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance use disorders in individuals with body dysmorphic disorder.
    Grant JE; Menard W; Pagano ME; Fay C; Phillips KA
    J Clin Psychiatry; 2005 Mar; 66(3):309-16; quiz 404-5. PubMed ID: 15766296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Service use and barriers to mental health care among adults with major depression and comorbid substance dependence.
    Chen LY; Crum RM; Martins SS; Kaufmann CN; Strain EC; Mojtabai R
    Psychiatr Serv; 2013 Sep; 64(9):863-70. PubMed ID: 23728427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender-specific effects of comorbid depression and anxiety on the propensity to drink in negative emotional states.
    Karpyak VM; Biernacka JM; Geske JR; Abulseoud OA; Brunner MD; Chauhan M; Hall-Flavin DK; Lewis KA; Loukianova LL; Melnyk GJ; Onsrud DA; Proctor BD; Schneekloth TD; Skime MK; Wittkopp JE; Frye MA; Mrazek DA
    Addiction; 2016 Aug; 111(8):1366-75. PubMed ID: 27009547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comorbid mental disorders in substance users from a single catchment area--a clinical study.
    Langås AM; Malt UF; Opjordsmoen S
    BMC Psychiatry; 2011 Feb; 11():25. PubMed ID: 21314980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the impact of comorbid depression on adolescent substance abuse treatment?
    Hersh J; Curry JF; Kaminer Y
    Subst Abus; 2014; 35(4):364-75. PubMed ID: 25157785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specialty behavioral health service use among chronically ill medicare advantage patients with substance use problems.
    Huang H; Chan YF; Bauer AM; Suzuki J; Katon W; Russo J; Hogan D; Unützer J
    Psychosomatics; 2013; 54(6):546-51. PubMed ID: 23932530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substance use problems and associated psychiatric symptoms among adolescents in primary care.
    Shrier LA; Harris SK; Kurland M; Knight JR
    Pediatrics; 2003 Jun; 111(6 Pt 1):e699-705. PubMed ID: 12777588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and correlates of alcohol and other substance use disorders in young adulthood: A population-based study.
    Latvala A; Tuulio-Henriksson A; Perälä J; Saarni SI; Aalto-Setälä T; Aro H; Korhonen T; Koskinen S; Lönnqvist J; Kaprio J; Suvisaari J
    BMC Psychiatry; 2009 Nov; 9():73. PubMed ID: 19925643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression.
    Chen LY; Strain EC; Crum RM; Mojtabai R
    J Addict Med; 2013; 7(5):325-34. PubMed ID: 24091763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
    Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
    Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long-term treatment outcomes of depression and anxiety comorbid with substance abuse.
    Bovasso G
    J Behav Health Serv Res; 2001 Feb; 28(1):42-57. PubMed ID: 11329998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological interventions for co-occurring depression and substance use disorders.
    Hides L; Quinn C; Stoyanov S; Kavanagh D; Baker A
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.